Yusong Zhang

1.6k total citations
57 papers, 1.2k citations indexed

About

Yusong Zhang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yusong Zhang has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yusong Zhang's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). Yusong Zhang is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). Yusong Zhang collaborates with scholars based in China, United States and Taiwan. Yusong Zhang's co-authors include Qiang Shen, Haijun Chen, Jia Zhou, Chunyong Ding, Zhengduo Yang, Jialong Tao, Jianhao Xu, Lili Chu, Na Yu and Christopher Wild and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Cancer Research.

In The Last Decade

Yusong Zhang

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yusong Zhang China 20 598 289 233 120 120 57 1.2k
Feng Jin China 22 558 0.9× 252 0.9× 164 0.7× 97 0.8× 265 2.2× 73 1.3k
Felicia Fei‐Lei Chung Malaysia 21 737 1.2× 327 1.1× 205 0.9× 75 0.6× 79 0.7× 44 1.3k
Takenori Takahata Japan 19 477 0.8× 377 1.3× 161 0.7× 56 0.5× 223 1.9× 50 1.3k
Julian C. Desmond United States 18 1.0k 1.7× 260 0.9× 138 0.6× 64 0.5× 91 0.8× 25 1.7k
Lanxiang Wu China 19 505 0.8× 146 0.5× 278 1.2× 46 0.4× 71 0.6× 41 918
Tianxin Yang China 21 671 1.1× 170 0.6× 120 0.5× 55 0.5× 79 0.7× 30 1.2k
Sakthivel Muniyan United States 23 656 1.1× 230 0.8× 120 0.5× 65 0.5× 88 0.7× 53 1.2k
Melvin Toh United States 14 513 0.9× 237 0.8× 108 0.5× 91 0.8× 60 0.5× 20 1.1k
Changzheng Li China 22 719 1.2× 240 0.8× 277 1.2× 123 1.0× 47 0.4× 78 1.4k

Countries citing papers authored by Yusong Zhang

Since Specialization
Citations

This map shows the geographic impact of Yusong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusong Zhang more than expected).

Fields of papers citing papers by Yusong Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusong Zhang. The network helps show where Yusong Zhang may publish in the future.

Co-authorship network of co-authors of Yusong Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Yusong Zhang. A scholar is included among the top collaborators of Yusong Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusong Zhang. Yusong Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hong, Hui, Qingze Zeng, Xiaopei Xu, et al.. (2024). Effect of cerebral small vessel disease on the integrity of cholinergic system in mild cognitive impairment patients: a longitudinal study. Journal of Neurology. 271(5). 2704–2715. 1 indexed citations
3.
Tao, Jialong, et al.. (2024). Efficacy and safety of gemcitabine plus raltitrexed or S-1 versus standard third-line therapies in metastatic colorectal cancer: a retrospective cohort study. Journal of Gastrointestinal Oncology. 15(2). 630–640. 1 indexed citations
4.
5.
Zhang, Yusong, et al.. (2023). Primary microcephaly gene CENPE is a novel biomarker and potential therapeutic target for non-WNT/non-SHH medulloblastoma. Frontiers in Immunology. 14. 1227143–1227143. 3 indexed citations
6.
Shen, Yu, Wei Liu, Yusong Zhang, et al.. (2023). Soy Protein Isolate Interacted with Acrylamide to Reduce the Release of Acrylamide in the In Vitro Digestion Model. Foods. 12(6). 1136–1136. 4 indexed citations
7.
8.
Peng, Simin, Na Yu, Jiaying Xu, et al.. (2020). The Geriatric Nutritional Risk Index as a Prognostic Factor in Patients with Advanced Non-Small-Cell Lung Cancer. Nutrition and Cancer. 73(11-12). 2832–2841. 22 indexed citations
9.
Zhang, Yusong, et al.. (2020). Inhibition of EZH2 attenuates inhibitory synaptic transmission via the pro-inflammatory pathway in rats. Neuropharmacology. 171. 108101–108101. 1 indexed citations
10.
Yu, Na, Jianhao Xu, Liwei Ni, et al.. (2019). Efficacy and safety of liposome-paclitaxel/liposome-paclitaxel combined with S-1 in 17 advanced gastric cancer patients with poor performance status. Translational Cancer Research. 8(5). 1690–1698. 2 indexed citations
11.
12.
Yang, Jinrong, Jiaying Xu, Guo‐Chong Chen, et al.. (2019). Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study. Scientific Reports. 9(1). 8143–8143. 38 indexed citations
13.
Ni, Liwei, Yuming Long, Jialong Tao, et al.. (2019). Mortality of site-specific cancer in patients with schizophrenia: a systematic review and meta-analysis. BMC Psychiatry. 19(1). 323–323. 41 indexed citations
14.
Zhang, Yusong, et al.. (2018). The role of the GLP-1/GLP-1R signaling pathway in regulating seizure susceptibility in rats. Brain Research Bulletin. 142. 47–53. 7 indexed citations
15.
Liu, Yulong, Youyou Wang, Hong Dai, et al.. (2016). Medical management of the victim exposed to 192Ir source at"5.7"accident in Nanjing. Zhonghua fangshe yixue yu fanghu zazhi. 36(5). 324–330. 2 indexed citations
16.
Chen, Lei, Qiang Chen, Zhixiang Zhuang, et al.. (2014). Effect of the Weekly Administration of Liposome–Paclitaxel Combined with S-1 on Advanced Gastric Cancer. Japanese Journal of Clinical Oncology. 44(3). 208–213. 5 indexed citations
17.
18.
Zhang, Yusong, et al.. (2013). Polydatin inhibits growth of lung cancer cells by inducing apoptosis and causing cell cycle arrest. Oncology Letters. 7(1). 295–301. 60 indexed citations
19.
Chen, Haijun, Zhengduo Yang, Chunyong Ding, et al.. (2013). Fragment-based drug design and identification of HJC0123 , a novel orally bioavailable STAT3 inhibitor for cancer therapy. European Journal of Medicinal Chemistry. 62. 498–507. 79 indexed citations
20.
Zhang, Hongyun, Jing Lei, Yiyun Chen, et al.. (2001). SYNTHESIS OF THE N,N′-BIS(FERROCENYLMETHYLENE)-1,2-PHENYLENEDIAMINE SCHIFF BASE AND SIX RARE EARTH METAL COMPLEXES. Synthesis and Reactivity in Inorganic and Metal-Organic Chemistry. 31(6). 973–981. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feng Jin Breakdown of academic impact, for papers by Felicia Fei‐Lei Chung Breakdown of academic impact, for papers by Takenori Takahata Breakdown of academic impact, for papers by Julian C. Desmond Breakdown of academic impact, for papers by Lanxiang Wu Breakdown of academic impact, for papers by Tianxin Yang Breakdown of academic impact, for papers by Sakthivel Muniyan Breakdown of academic impact, for papers by Melvin Toh Breakdown of academic impact, for papers by Changzheng Li
Rankless by CCL
2026